Tuesday, December 24, 2019

Enhertu Approved for Unresectable, Metastatic HER2+ Breast Cancer

Title: Enhertu Approved for Unresectable, Metastatic HER2+ Breast Cancer
Category: Health News
Created: 12/23/2019 12:00:00 AM
Last Editorial Review: 12/24/2019 12:00:00 AM

from MedicineNet Daily News https://ift.tt/2MrCfAa
via IFTTT

0 comments:

Post a Comment